SQUAWK/NEWS
Menu
Live News EQUITY L impact

Gyre Therapeutics Files SEC Form

Gyre Therapeutics submits filing to SEC, disclosure pending

GYRE

Filed: 2026-05-27 AccNo: 0001140361-26-022980 Size: 13 KB